The cost of pharmaceuticals is a major contributor to the dramatic escalation in the cost of health care in the United States. In response to growing concern that the cost of pharmaceuticals has outpaced the ability of many citizens to afford appropriate care, the United States Congress enacted Section 340B of the Public Health Services Act (PHSA) in 1992. This legislation was enacted to provide medically and financially vulnerable populations greater access to medication by offering steep discounts for pharmaceuticals to covered entities.

AmeriChoice is an industry leader in consulting services that show clients how to maximize their pharmaceutical savings. The net effect is that we can help clients save money and improve the health and safety of patients in a cost-effective manner. The AmeriChoice Strategic Health Care Consulting Team has worked collaboratively with a large philanthropic organization to assess current pharmacy cost containment systems; develop and submit 340B program applications; develop and implement 340B programs; and implement reporting and monitoring strategies to ensure achievement of cost savings goals.